Your browser doesn't support javascript.
loading
Targeting non-canonical pathways as a strategy to modulate the sodium iodide symporter.
Read, Martin L; Brookes, Katie; Thornton, Caitlin E M; Fletcher, Alice; Nieto, Hannah R; Alshahrani, Mohammed; Khan, Rashida; Borges de Souza, Patricia; Zha, Ling; Webster, Jamie R M; Alderwick, Luke J; Campbell, Moray J; Boelaert, Kristien; Smith, Vicki E; McCabe, Christopher J.
Affiliation
  • Read ML; Institute of Metabolism and Systems Research (IMSR), and Centre of Endocrinology, Diabetes and Metabolism (CEDAM), University of Birmingham, Birmingham B15 2TT, UK.
  • Brookes K; Institute of Metabolism and Systems Research (IMSR), and Centre of Endocrinology, Diabetes and Metabolism (CEDAM), University of Birmingham, Birmingham B15 2TT, UK.
  • Thornton CEM; Institute of Metabolism and Systems Research (IMSR), and Centre of Endocrinology, Diabetes and Metabolism (CEDAM), University of Birmingham, Birmingham B15 2TT, UK.
  • Fletcher A; Institute of Metabolism and Systems Research (IMSR), and Centre of Endocrinology, Diabetes and Metabolism (CEDAM), University of Birmingham, Birmingham B15 2TT, UK.
  • Nieto HR; Institute of Metabolism and Systems Research (IMSR), and Centre of Endocrinology, Diabetes and Metabolism (CEDAM), University of Birmingham, Birmingham B15 2TT, UK.
  • Alshahrani M; Institute of Metabolism and Systems Research (IMSR), and Centre of Endocrinology, Diabetes and Metabolism (CEDAM), University of Birmingham, Birmingham B15 2TT, UK.
  • Khan R; Institute of Metabolism and Systems Research (IMSR), and Centre of Endocrinology, Diabetes and Metabolism (CEDAM), University of Birmingham, Birmingham B15 2TT, UK.
  • Borges de Souza P; Section of Endocrinology, Department of Medical Sciences, University of Ferrara, Ferrara 44124, Italy.
  • Zha L; Institute of Metabolism and Systems Research (IMSR), and Centre of Endocrinology, Diabetes and Metabolism (CEDAM), University of Birmingham, Birmingham B15 2TT, UK.
  • Webster JRM; Protein Expression Facility, College of Medical and Dental Sciences, University of Birmingham, B15 2TT, UK.
  • Alderwick LJ; Birmingham Drug Discovery Facility, School of Biosciences, University of Birmingham, Birmingham B15 2TT, UK.
  • Campbell MJ; Division of Pharmaceutics and Pharmacology, The Ohio State University, College of Pharmacy, Columbus, OH 43210, USA.
  • Boelaert K; Institute of Applied Health Research, University of Birmingham, Birmingham B15 2TT, UK.
  • Smith VE; Institute of Metabolism and Systems Research (IMSR), and Centre of Endocrinology, Diabetes and Metabolism (CEDAM), University of Birmingham, Birmingham B15 2TT, UK.
  • McCabe CJ; Institute of Metabolism and Systems Research (IMSR), and Centre of Endocrinology, Diabetes and Metabolism (CEDAM), University of Birmingham, Birmingham B15 2TT, UK. Electronic address: mccabcjz@bham.ac.uk.
Cell Chem Biol ; 29(3): 502-516.e7, 2022 03 17.
Article in En | MEDLINE | ID: mdl-34520744
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Symporters / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Cell Chem Biol Year: 2022 Type: Article Affiliation country: United kingdom
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Symporters / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Cell Chem Biol Year: 2022 Type: Article Affiliation country: United kingdom